Professor of Medicine, University S Fla College of Medicine
Hematology
Dr. Benjamin Djulbegovic, MD
|
|
Give Review
Benjamin Djulbegovic practices Hematology. He received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Benjamin Djulbegovic is a published physician. He published 62 publications, including: 'Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.' Doctor Benjamin Djulbegovic, MD is registered with Medicare.
Publications
- The role of iron in the management of chemotherapy-induced Anemia in cancer patients receiving erythropoiesis-stimulating agents.
- GRADE guidelines System is reproducible when instructions are clearly operationalized even among the guidelines panel members with limited experience with GRADE.
- Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular Disease.
- Those Responsible for Approving Research Studies Have Poor Knowledge of Research Study Design: a Knowledge Assessment of Institutional Review Board Members.
- Modern health care as a game theory problem: reply.
- When is rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation.
- Evidence synthesis and guideline development in genomic medicine: current status and future prospects.
- Platelet transfusion: a Systematic review of the clinical evidence.
- Modern health care as a game theory problem.
- Uncertainty about effects is a key factor influencing institutional review boards' approval of clinical studies.
- Study design and the drug development process--reply.
- Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies.
- Human Judgment and Health Care Policy.
- A framework to bridge the gaps between evidence-based medicine, health outcomes, and improvement and implementation science.
- Evaluation of Physicians' Cognitive Styles.
- Defining Optimum Treatment of Patients With Pancreatic Adenocarcinoma Using Regret-Based Decision Curve Analysis.
- Treatment-related harms: What was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a Systematic re...
- Sequence of novel agents in multiple Myeloma: An instrumental variable analysis.
- Gemtuzumab ozogamicin for treatment of newly diagnosed Acute myeloid leukaemia: a systematic review and meta-analysis.
- Value of Repeat Head Computed Tomography after Traumatic Brain Injury: Systematic Review and Meta-Analysis.
- Medical research: Trial unpredictability yields predictable therapy gains.
- Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients With metastatic colorecta...
- Adherence to antiretroviral therapy in India: a Systematic review and meta-analysis.
- Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic Leukemia: a multiple-treatment meta-analysis.
- Colony-stimulating factors for febrile Neutropenia during cancer therapy.
- Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error.
- Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients With newly diagnosed multiple myeloma...
- Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: A...
- When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guilt.
- Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation With conventional chemo-(immuno) therapy in patients With relapsed or refractory C...
- Bisphosphonates in multiple Myeloma: a network meta-analysis.
- Antithymocyte globulin for Acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review.
- Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols.
- From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep.
- Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a Systematic review.
- Timing of first-line cancer treatments - early versus late - a Systematic review of phase III randomized trials.
- Where is the wisdom? II - Evidence-based medicine and the epistemological crisis in clinical medicine. Exposition and commentary on Djulbegovic, B., Guyatt, G. H. & A...
- A late and shifting foundation: a commentary on Djulbegovic, B., Guyatt, G. H. & Ashcroft, R. E. (2009) Cancer Control, 16, 158-168.
- The search for substance: a quest for the identity-conditions of evidence-based medicine and some comments on Djulbegovic, B., Guyatt, G. H. & Ashcroft, R. E. (2009) C...
- EBM: a narrow and obsessive methodology that fails to meet the knowledge needs of a complex adaptive clinical world: a commentary on Djulbegovic, B., Guyatt, G. H. & A...
- More of the same: a commentary on Djulbegovic, B., Guyatt, G. H. & Ashcroft, R. E. (2009) Cancer Control, 16, 158-168.
- Evidence-based medicine: requiescat in pace? A commentary on Djulbegovic, B., Guyatt, G. H. & Ashcroft, R. E. (2009) Cancer Control, 16, 158-168.
- The Zombie science of evidence-based medicine: a personal retrospective. A commentary on Djulbegovic, B., Guyatt, G. H. & Ashcroft, R. E. (2009). Cancer Control, 16, 1...
- Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a Systematic review and meta-analysis.
- Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach.
- Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
- Estimating the mean and variance from the median, range, and the size of a sample.
- Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in Hemophilia B.
- Concomitant treatment with factor IX concentrates and antifibrinolytics in Hemophilia B.
- Guidelines for management of Hemophilia A and B.
- Mathematical modeling or waiting decades for an empirical answer?
- Disseminated intravascular Coagulation after factor IX complex resolved using purified factor IX concentrate.
- A new algorithm for the diagnosis of polycythemia.
- Comparison of different treatment strategies for diffuse large-cell Lymphomas: a decision analysis.
- Colony-stimulating factors for chemotherapy-induced febrile Neutropenia.
- Benchmarks for detecting 'breakthroughs' in clinical trials: empirical assessment of the probability of Large treatment effects using kernel density estimation.
- How do physicians decide to treat: an empirical evaluation of the threshold model.
- External validation of a web-based prognostic tool for predicting survival for patients in hospice care.
- At what level of collective equipoise does a randomized clinical trial become ethical for the members of institutional review board/ethical committees?
- Rapid Infusion Rituximab for Maintenance Therapy: Is It Feasible?
- Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.
Schools
University Of Sarajevo Faculty Of Medicine
University Med Center
University Of Louisville
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Hospital
-
Memorial Hospital of Tampa -
Tampa General Hospital
Drug Facts
| NPI NUMBER | 1649201740 | |
| NPPES Provider LastName | DJULBEGOVIC | |
| NPPES Provider FirstName | BENJAMIN | |
| NPPES Provider ZIPCode | 336124742 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology | |
| Total Claim Count | 150.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 32.0 | |
| Percent Opioid Claims | 21.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649201740 |
| Last Name Of The Provider | DJULBEGOVIC |
| First Name Of The Provider | BENJAMIN |
| View All |
Similar Doctors
|
|
Dr. Jinming Song, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ron D. Schiff, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bijal D. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rachid C. Baz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Frank B. Lane Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jose L. Ochoa-Bayona, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hatem Soliman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey Lancet, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Loveleen Kang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Weaver, MD |
|
|
Dr. Ateefa Chaudhury, MD
This Doctor is OpenDoctor Recommended.
|